These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 19594743

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.
    Vyas P, Roberts I.
    Early Hum Dev; 2006 Dec; 82(12):767-73. PubMed ID: 17064858
    [Abstract] [Full Text] [Related]

  • 3. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
    Cushing T, Clericuzio CL, Wilson CS, Taub JW, Ge Y, Reichard KK, Winter SS.
    J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
    [Abstract] [Full Text] [Related]

  • 4. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
    Carpenter E, Valverde-Garduno V, Sternberg A, Mitchell C, Roberts I, Vyas P, Vora A.
    Br J Haematol; 2005 Feb; 128(4):548-51. PubMed ID: 15686466
    [Abstract] [Full Text] [Related]

  • 5. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL.
    Haemmerling S, Behnisch W, Doerks T, Korbel JO, Bork P, Moog U, Hentze S, Grasshoff U, Bonin M, Rieß O, Janssen JW, Jauch A, Bartram CR, Reinhardt D, Koch KA, Bandapalli OR, Kulozik AE.
    Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450
    [Abstract] [Full Text] [Related]

  • 6. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
    Xu G, Kato K, Toki T, Takahashi Y, Terui K, Ito E.
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
    [Abstract] [Full Text] [Related]

  • 7. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
    Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD.
    Blood Cells Mol Dis; 2003 Oct; 31(3):351-6. PubMed ID: 14636651
    [Abstract] [Full Text] [Related]

  • 8. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C, Creutzig U, Reinhardt D.
    Klin Padiatr; 2005 Oct; 217(3):126-34. PubMed ID: 15858703
    [Abstract] [Full Text] [Related]

  • 9. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
    Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G, Kempski H, Haas OA, Izraeli S.
    Blood; 2003 Aug 01; 102(3):981-6. PubMed ID: 12649131
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D, Reinhardt K, Neuhoff C, Sander A, Klusmann JH, Pekrun A, Sauerbrey A, von Stackelberg A, Rössig C, Creutzig U, Kolenova A.
    Klin Padiatr; 2012 Apr 01; 224(3):153-5. PubMed ID: 22513796
    [Abstract] [Full Text] [Related]

  • 14. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
    Ariffin H, Garcia JC, Daud SS, Ibrahim K, Aizah N, Ong GB, Chong LA, Mohamad Z.
    Pediatr Blood Cancer; 2009 Jul 01; 53(1):108-11. PubMed ID: 19260099
    [Abstract] [Full Text] [Related]

  • 15. Natural history of GATA1 mutations in Down syndrome.
    Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P.
    Blood; 2004 Apr 01; 103(7):2480-9. PubMed ID: 14656875
    [Abstract] [Full Text] [Related]

  • 16. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
    Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH.
    Nat Genet; 2005 Jun 01; 37(6):613-9. PubMed ID: 15895080
    [Abstract] [Full Text] [Related]

  • 17. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.
    Hama A, Yagasaki H, Takahashi Y, Nishio N, Muramatsu H, Yoshida N, Tanaka M, Hidaka H, Watanabe N, Yoshimi A, Matsumoto K, Kudo K, Kato K, Horibe K, Kojima S.
    Br J Haematol; 2008 Mar 01; 140(5):552-61. PubMed ID: 18275433
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute megakaryoblastic leukemia in Down syndrome.
    Hitzler JK.
    Pediatr Blood Cancer; 2007 Dec 01; 49(7 Suppl):1066-9. PubMed ID: 17943965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.